« Back to news listing

TriVascular Technologies files for $100 million IPO

TriVascular Technologies, which has developed a new stent graft platform to treat aortic aneurysms, filed on Monday with the SEC to raise up to $100 million in an initial public offering.

Read entire article: http://www.nasdaq.com/article/medical-device-maker-trivascular-technologies-files-for-a-100-million-ipo-cm333991

« Back to news listing